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Abstract
Background: Patients with Crohn’s disease (CD) are frequently subjected to computed tomography (CT) in the emergency
department (ED). This young population is at higher risk of malignancy from radiation exposure.
Objectives: We aimed to validate a decision tool predicting complications (perforation, abscess or other serious finding) on
imaging at two sites.
Methods: We conducted a retrospective review of CT outcomes among patients with CD with ED visits at two tertiary care
centers. Inclusion criteria were a CT of the abdomen/pelvis with contrast and complete lab data (erythrocyte sedimentation
rate (ESR) and C-reactive protein (CRP)) within 24 hours of arrival at the University of Michigan (UM) (2012–2013) and the
University of Pittsburgh (UPMC) (2009–2012). Sensitivity, negative predictive value (NPV), miss rate and CT avoidance rate
were calculated.
Results: At UPMC (n¼ 210), the tool had a sensitivity of 88.9% and NPV of 98.0%, potentially saving 47.1% from CT with a
miss rate of 1.0%. At UM (n¼ 248), the tool had a sensitivity of 90.9% and NPV of 96.0%, saving 40.3% from CT with a miss
rate of 1.6%.
Conclusion: A decision tool using CRP and ESR predicting CT outcomes among CD patients performed well in an external
validation, allowing providers to forgo CT use with a low miss rate.
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Introduction
Patients with Crohn’s disease (CD) are particularly vul-
nerable to multiple computed tomography (CT) scans
over their lifetimes. Because their illness is chronic with
frequent but variable flares, these patients often seek
care in the emergency department (ED).1 During
these ED visits, providers must decide whether CT ima-
ging would be useful in evaluating for clinically import-
ant CD complications such as perforation or abscess.
However, the benefits of CT must be balanced with
downside risks such as cumulative exposure to the
ionizing effects of radiation,2 allergic reaction to con-
trast agents,3 contrast-induced nephropathy,4 and
unnecessary additional testing from incidental findings.
High cumulative radiation exposure in this young
population is particular problematic. Approximately
10% of the IBD population is exposed to more than
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50mSv of radiation, a level associated with an
increased risk of malignancy.5,6
In order to help providers better risk-stratify patients
who would least benefit from CT imaging, we devel-
oped decisions tools that predict the presence of com-
plications in patients with CD presenting to the ED.7
These decision tools use only C-reactive protein (CRP)
and erythrocyte sedimentation rate (ESR) in a logistic
regression equation to predict the presence of perfor-
ation, abscess or another serious finding with good per-
formance characteristics. Using cross-validation, we
found that sensitivity to be 93.8%, the negative predict-
ive value (NPV) to be 98.1% and the miss rate to be
0.8%. Using the tool would have saved up to 43% of
patients from undergoing CT. An online calculator can
be found at www.crohnsctrisk.info. We also created a
simple decision tool that can be calculated by hand.
While this tool had similar performance characteristics,
it would have prevented only 18.5% of the patients
from further radiation exposure.
Our aim here is to validate the previously derived
clinical decision tools by analyzing their performance
characteristics on two additional patient cohorts. The
first is an external cohort from the University of
Pittsburgh Medical Center (UPMC) while the second
is a cohort from the University of Michigan (UM) from
later years (2012–2013).
Methods
The electronic medical records systems of both institu-
tions were searched for ED visits for patients 18 years
of age with a diagnosis of CD based on the
International Classification of Diseases, ninth revision
(ICD-9) coding (555.x), which included a CT scan of
the abdomen and pelvis. At UPMC, visits between
January 1, 2009 and December 31, 2012 were analyzed.
At UM, records were requested for visits between
January 1, 2012 and December 31, 2013. ED and sub-
sequent visits were reviewed to verify a diagnosis of CD
and to determine medications, admission status and
chief complaint. CT reports from within 24 hours of
the ED visit were requested and reviewed to determine
findings. CTs were excluded if both oral and intraven-
ous contrast were not administered as contrast would
be required to maximize the probability of detecting
complications of disease. CT reads of scans performed
at external facilities (external to UPMC or UM) or for
an indication of trauma were also excluded. Only visits
with both ESR and CRP drawn within 24 hours of
arrival were included in the analysis. No imputation
was performed for missing labs.
The records from UPMC were de-identified prior to
analysis. All records were evaluated by one reviewer
(SMG) who was blinded to the lab results.
Complications were characterized in the same
manner as in the original decision tool derivation.7
Complications consisted of perforations, abscess, or
another serious finding that may change management
(not including inflammation). Obstruction was not
included in the complications model as we found that
obstruction is a clinical diagnosis that could not be reli-
ably predicted in the derivation process. The findings
that constitute complications are found in Table 1. The
enterography protocol is used at UM but not at
UPMC. Institutional review boards approved this pro-
ject at both sites prior to data collection.
The logistic regression tool is e^(0.0953*CRPþ
0.0189*ESR–3.206)/1þe^(0.0953*CRPþ0.0189*ESR–
3.206) where CRP is in mg/dl. The cutoff used with this
equation is 0.06 with a very low probability of a signifi-
cant finding with results below this. The simple decision
tool is calculated by ESRþ5*CRP (mg/dl) with a cutoff
of 10 or less.
Statistical methods
Descriptive statistics were calculated comparing each
validation cohort with the derivation cohort using the
student’s t-test for numerical variables and the chi
square test for categorical variables. The sensitivity,
NPV, and area under the receiver operating character-
istic (AuROC) curve are reported for each site and
Table 1. CT findings at UM and UPMC








Abscess 104 (9.5) 43 (13.7) 39 (7.8)
Obstruction 108 (10.0) 39 (12.4) 42 (8.4)
Perirectal abscess 25 (2.3) 10 (3.2) 16 (3.2)
Perforation 15 (1.4) 4 (1.3) 10 (2.0)
Urolithiasis with
complication
3 (0.3) 4 (1.3) 2 (0.4)
Diverticulitis 12 (1.1) 2 (0.6) 2 (0.4)
Pancreatitis 9 (0.8) 2 (0.6) 4 (0.8)
Pyelonephritis 2 (0.2) 0 (0) 2 (0.4)
Other serious findinga 10 (0.9) 6 (1.9) 8 (1.6)
Inflammation 597 (54.5) 192 (60.9) 248 (49.7)
Complications 184 (16.8) 67 (21.3) 80 (16.0)
aUM validation: cholangitis, bowel ischemia, incarcerated umbilical hernia,
psoas myositis, osteomyelitis, angioedema; UPMC validation: two instances
of pneumonia, pericarditis, pouchitis, IMV thrombosis, intussception, DVT,
hydrosalpinx.
CT: computed tomography; UM: University of Michigan; UPMC: University of
Pittsburgh Medical Center; IMV: inferior mesenteric vein; DVT: deep vein
thrombosis.
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for each equation (logistic regression and simple for-




From 2009 to 2012, there were 802 ED visits among 458
patients with Crohn’s at UPMC. After applying exclu-
sion criteria (see Figure 1), 499 visits representing
308 individuals were reviewed. Laboratory data were
complete in 210 cases. Demographic and medication
comparisons between the UPMC validation cohort
and the UM derivation cohort are presented in
Table 2. Most patients had a chief complaint of abdom-
inal pain leading to their ED visit.
The percentage of patients with complications on CT
was 15.6%, but among those with complete lab data,
the complication rate was 9.5% (Table 1). Among
patients with missing ESR and/or CRP, the complica-
tion rate was 20.8%. Inflammation was found in 49.7%
of CTs.
The logistic regression decision tool for complica-
tions had a sensitivity of 88.9%, NPV of 98.0% and
miss rate of two out of 210 (1.0%) while possibly saving
47.1% of the cohort from CT. The simple decision tool
for complications had a sensitivity of 88.9%, NPV of
93.1% and miss rate of 1.0%. Using the simple tool
would have saved only 13.8% of the patients from radi-
ation. The AuROC for the logistic regression decision
tool for complications was 0.78 with a 95% confidence
interval (CI) of 0.63–0.92 (Figure 2).
The two cases missed by the logistic regression deci-
sion tool included an instance of intussusception and
urolithiasis. Both patients were managed conservatively
without operative intervention.
UM temporal validation
Between 2012 and 2013, there were 405 ED visits
among patients with CD. Applying the exclusion cri-
teria, there were 315 eligible visits by 220 individuals
during this time period (Figure 1). Demographics and
medication comparisons between the validation and
derivation cohort are displayed in Table 2. The admis-
sion rate among this cohort remained very high, at
91.4%.
The CT findings demonstrated complications in
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lack of IV/oral contrast
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lack of IV/oral contrast






with ESR and CRP
Figure 1. Consolidated Standards of Reporting Trials (CONSORT)-style diagram demonstrating the sample size after applying the
exclusion criteria at each institution.
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and frequency are shown in Table 1). ESR and CRP
were both available for 248 visits and 43.5% were per-
formed with a CT enterography protocol. Patients with
a CRP and ESR were less likely to have a complication
on CT (17.7%) compared to patients with one or both
labs missing (31.3%) (p¼ 0.01).
Using the logistic regression decision tool to predict
complications, the sensitivity of the algorithm was
90.9% and the NPV was 96.0%. Of the 248 patients
scanned with complete lab data, four patients were
incorrectly predicted as not having a complication for
a miss rate of 1.6%. The benefit of this tool is that
100 patients (40.3%) would have been saved from fur-
ther radiation. The AuROC for the logistic regression
model for complications was 0.78 (95% CI: 0.72–0.86)
(Figure 2). The simple decision tool had a sensitivity of
97.7%, NPV of 98.0% and a miss rate of 0.4% while
saving 20% of the patients from further radiation
exposure.
Among the UM validation population, the
four missed cases included two instances of abdom-
inal abscess, one case of bowel ischemia, and one
perianal abscess. The patient with bowel ischemia was
known to have a significant bowel obstruction based
on a CT obtained less than 48 hours earlier at
another facility and underwent reduction of the para-
stomal hernia four days after arrival. The patient with
perirectal abscess did go to the operating room for
examination under anesthesia but was not found
to have a drainable fluid collection. One of the
patients with an abscess was known to have a prior
abscess requiring percutaneous drainage; the patient
was taken to the operating room for incision and drain-
age on this occasion. The other patient with an abscess
presented with a fluctuant mass at his ostomy and
underwent percutaneous aspiration of the fluid
collection.
Table 2. Population characteristics and comparison to derivation population
Derivation set Validation set p value





Age 38.2 (14.6) 37.7 (14.2) 36.1 (13.1) 0.63 <0.01
Female (%) 573 (52.3) 161 (51.1) 245 (49.1) 0.7 0.23
Race 0.08 0.25
White 940 (85.8) 263 (83.5) 442 (88.6)
Black 129 (11.8) 37 (11.8) 50 (10.0)
Other 26 (2.4) 15 (4.8) 7 (1.4)
Steroid use 306 (28.0) 73 (23.2) 78 (15.6) 0.09 <0.01
Immunomodulator use 402 (36.7) 138 (43.8) 115 (23.1) 0.02 <0.01
Biologic use 232 (21.2) 103 (32.7) 155 (31.1) <0.01 <0.01
Ciprofloxacin use 77 (7.0) 23 (7.3) 35 (7.0) 0.87 0.99
Metronidazole use 85 (7.8) 23 (7.3) 38 (7.6) 0.79 0.92
Narcotic use 328 (30.0) 98 (31.1) 175 (35.1) 0.69 0.05
5-ASA use 413 (37.7) 67 (21.3) 70 (14.1) <0.01 <0.01
Admission 974 (89.0) 288 (91.4) 386 (77.4) 0.21 <0.01

















0.80 (0.74 - 0.86)
95%CI
0.78 (0.72 - 0.86)
0.78 (0.63 - 0.92)
Figure 2. The receiver operating characteristic (ROC) curves for
the derivation logistic regression decision tool and validation
logistic regression decision tool are displayed.
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Discussion
In an attempt to help providers better select patients
who could avoid further radiation, we developed equa-
tions using easily available labs with a high NPV. In
our derivation set, we were able to save 43% of patients
from further radiation exposure. Here, we have demon-
strated in two separate validation cohorts that our
logistic regression equation consisting of ESR and
CRP is able to save more than 40% of patients from
further radiation exposure with a high NPV. Both of
these labs tests (CRP, ESR) are widely available, inex-
pensive, and have a rapid turnaround time. Further, we
have been able to build this multianalyte algorithmic
test into our laboratory information system and incorp-
orate the results into the electronic medical records
system at UM, with an estimated turnaround time of
90 minutes.
Preventing 40% of the CD population presenting to
the ED from undergoing CT has significant implica-
tions on health care costs, cancer prevention and the
rare risk of contrast-induced nephropathy in this popu-
lation. The cost of a CT abdomen and pelvis according
to the most recent Medicare reimbursement tables is
$327.8 Using the assumptions that there are 540,000
patients with CD in the United States9 and that on
average they each obtain one CT every decade, appli-
cation of the logistic algorithm would produce a cost
savings of $70 million a decade. Using the same
assumptions regarding the prevalence of Crohn’s and
the frequency of CT use along with the assumption that
for every 910 CTs performed,10 there will be 1 addi-
tional cancer, the logarithmic decision tool could pre-
vent 23 additional cancers each year. For patients
below the age of 35 who are particularly at risk from
repeated radiation exposure,11 this decision tool could
help providers use alternative imaging modalities such
as magnetic resonance imaging (MRI) or ultrasound
for those who are not below the cutoff.
While we believe the NPVs of this decision tool are
acceptably high, a potential barrier to their widespread
use in the community could be a mindset that any NPV
less than 100% is not good enough. For comparison,
the NPV of procalcitonin as a marker of infection is
94%–98% at typically used cutoffs,12 and the NPV for
CT in the diagnosis of acute appendicitis is 94%–
95%.13,14 Much like the use of d-dimer to rule out pul-
monary embolism (PE) in low-risk populations, we
would recommend the use of these equations in patients
with moderate suspicion for a positive finding. Studies
at other large tertiary care institutions have identified
that patients with a prior history of surgery, abdominal
abscess or obstruction, and those that have tachycardia
or are underweight (body mass index (BMI) <18.5) are
more likely to have significant findings on CT.15,16
We would suggest that a high pretest likelihood to
scan should be applied to patients with these
characteristics.
Conversely, there could be a paradoxical increase in
CT use if our decision tool were to be used too broadly
and applied to very low-risk patients whose providers
would not have even considered obtaining a CT. In our
derivation cohort, we noted that providers were quite
good at identifying very low-risk patients who did not
need a CT.7 Of those patients who returned to the ED
within 30 days after a visit that did not include a CT,
28% underwent a CT on the return visit and none had a
complication.
Potential limitations to the use of this decision tool
include the inability to identify obstructions as a com-
plication, the frequent use of non-contrast studies, and
the possible lack of generalizability to patients seen in
the community rather than tertiary centers. For the
purpose of this tool, we characterized obstruction as a
CT finding consistent with obstruction coupled with the
need for nasogastric (NG) tube decompression or a
surgical procedure. Reclassifying obstruction as those
with consistent imaging requiring a surgical procedure
revealed changed the obstruction rate from 10.0% to
2.3%. Among patients who present with signs or symp-
toms of an obstruction such as nausea or vomiting, it
would be reasonable to start with an acute abdominal
series as a screening test prior to cross sectional ima-
ging. Non-contrast CT is frequently used in the ED
among patients with CD because of the quick turn-
around. We did not study non-contrast CT scans
since they may not identify outcomes such as abscess.
Ideally, we would limit our studies to enterography
protocol CTs, but these studies are used infrequently
in the ED. In regards to generalizability, the complica-
tion rate was higher among patients with missing labs
at both centers. It is possible that patients who did not
have these labs drawn presented with more obvious
signs of a complication (fever, peritoneal signs) and
providers did not feel these labs were needed to make
a decision regarding imaging. The use of this tool also
may be limited by the availability of ESR throughout
the day at other centers. Our institution is able to
perform this test throughout the day, but other
centers internationally may not have this availability.
Prospective studies are needed to determine the impact
of this algorithm in practice.
In conclusion, we have validated risk stratifi-
cation algorithms based on CRP and ESR in two dis-
tinct cohorts. These algorithms can help providers
identify patients with CD who are at very low prob-
ability of having a complication on CT and avoid
further radiation. Further prospective studies will
have to be performed to study the effect of implemen-
tation of these algorithms on CT use in CD patients in
the ED.
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